Tag: staging

Quick Search


Understanding Your Biopsy Results

Sun 1 Jul 2012

Download – The Biopsy Pathology Report The Pathology Report from a biopsy (often labeled “surgical pathology report”) relays critical information about the biologic expression of the tumor. When tissue is removed from your body, it is sent to a pathologist, who examines it under a microscope and prepares a formal written report. You should requestRead More ›

Prostate Cancer Algorithms/Nomograms

Wed 31 Aug 2011

Predictive algorithms and nomograms combine multiple variables to provide information that is statistically more significant than any individual variable. A nomogram is “an objective tool that uses an algorithm or mathematical formula to predict the probability of an outcome”. These tools can give probabilities of cancer location or of treatment success, based on scientific studiesRead More ›

MRI In Prostate Cancer

Sun 30 Nov 2008

Jelle Barentsz, M.D., Ph.D Professor of Radiology – Chairman for Research Department of Radiology University Medical Center – St. Radboud Nijmegen Nijmegen, The Netherlands Edited from PCRI Insights November, 2008 v 11.4 Editor’s Note: This paper discusses ferumoxtran-10 (Combidex). AMAG Pharmaceuticals has discontinued the manufacture of Ferumoxtran-10 in 2010 making Combidex no longer available. TheyRead More ›

What We Should Have Learned About Prostate Cancer (PC) in the Past 10 Years: Part Three

Sun 31 Aug 2008

  by Stephen B. Strum, MD, FACP Medical Oncologist and PCRI Co-founder Ashland, OR Edited from PCRI Insights August, 2008 v 11.3 In Part I and Part II of this series, I presented an in-depth discussion of key issues relating to the chemoprevention of PC, and I discussed in depth the results of the PCPTRead More ›

Magnetic Resonance Anatomic and Spectroscopic Imaging of Prostate Cancer – Current Status

Wed 1 Nov 2006

John Kurhanewicz, Christopher K. Sotto and Fergus Coakley Department of Radiology, University of California San Francisco Edited from PCRI Insights November, 2006 vol. 9 no. 4   Magnetic Resonance Imaging (MRI) Development of Magnetic Resonance Imaging (MRI) as a clinically useful technique for the assessment of prostate cancer has been a major focus at theRead More ›

Using Nomograms to Predict Pathological Stage and Treatment Outcome for Patients with Prostate Cancer

Wed 30 Nov 2005

Edited from PCRI Insights November 2005 vol. 8 no. 4 By Glenn Tisman, MD Many times during the course of my oncology practice I have been made to feel like a referee of a dispute between the urological surgeon and the radiation therapist as they vie for center stage in the treatment of the prostateRead More ›

Ferumoxtran-10: An Important New Prostate Cancer Staging Tool

Mon 1 Nov 2004

PCRI Insights November 2004 vol. 7, no. 4 By Maha Torabi, MD and Mukesh G. Harisinghani, MD, Department of Radiology, Massachusetts General Hospital, Boston, MA Editor’s Note: This paper discusses ferumoxtran-10 (Combidex). AMAG Pharmaceuticals has discontinued the manufacture of Ferumoxtran-10 in 2010 making Combidex no longer available. They are currently pursuing approval of ferumoxytol asRead More ›

The Way to Find the Best Available Treatment for Your PC: Advice for Men Newly Diagnosed with Prostate Cancer

Tue 31 Aug 2004

PCRI Insights August, 2004 vol. 7, no. 3 By Mark Scholz, M.D., Prostate Oncology Specialists “You mean you’ve never heard of spectroscopy being used in prostate cancer staging?” Don, a recently diagnosed prostate cancer (PC) patient, was astonished to learn that the doctor treating him was unaware of this application of this new technology. DonRead More ›

Newly Diagnosed Prostate Cancer: Evaluating the Options — Part 3 of 3

Sat 21 Feb 2004

Reprinted from PCRI Insights February 2004 v 7.1 By Mark Scholz, M.D., Prostate Oncology Specialists, Marina del Rey, CA Background This is the third article of a three-part series describing treatment alternatives for newly diagnosed prostate cancer patients. In this part, treatment for men who are at higher risk for micro-metastatic spread outside the prostateRead More ›

Update on ProstaScint®: CT and MRI Fusion as Diagnostic Tools

Fri 1 Aug 2003

By Samuel Kipper, M.D., Pacific Coast Imaging, Irvine, CA Reprinted from PCRI Insights August 2003 vol. 6, no. 3 Prostate cancer management has advanced significantly over the last decade, most notably with improved methods of risk stratification, which allow for more appropriate treatment selection for individual patients based on their individual prognostic factors. Some ofRead More ›